Yalong Wang

689 total citations
23 papers, 393 citations indexed

About

Yalong Wang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yalong Wang has authored 23 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Yalong Wang's work include Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (7 papers) and RNA modifications and cancer (3 papers). Yalong Wang is often cited by papers focused on Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (7 papers) and RNA modifications and cancer (3 papers). Yalong Wang collaborates with scholars based in China, United States and Netherlands. Yalong Wang's co-authors include Shu Zhu, Mark T. Bedford, Yin Huang, Yufang Shi, Youcun Qian, Yikun Yao, Qibin Leng, Fuxiang Chen, Hongyan Wang and Tingting Wan and has published in prestigious journals such as Nature Communications, Nano Letters and Biochemical Journal.

In The Last Decade

Yalong Wang

20 papers receiving 392 citations

Peers

Yalong Wang

IMMUN

ONCOL

NEURO

Egon Urgard Estonia

Fabien Richard France

Dunja Ferring–Appel Germany

Sihao Zheng China

Alessia Capone Italy

Chengkui Yang China

Teresa R. Pacheco Portugal

Yaqi Xu China

Hongyang Yi China

Viviane Ponath Germany

Egon Urgard Estonia

Yalong Wang

242 ×1.2

70 ×0.7

IMMUN

31 ×0.7

ONCOL

13 ×0.4

NEURO

9 ×0.3

Citations per year, relative to Yalong Wang Yalong Wang (= 1×) peers Egon Urgard

Countries citing papers authored by Yalong Wang

Since Specialization

Citations

This map shows the geographic impact of Yalong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalong Wang more than expected).

Fields of papers citing papers by Yalong Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yalong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalong Wang. The network helps show where Yalong Wang may publish in the future.

Co-authorship network of co-authors of Yalong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yalong Wang. A scholar is included among the top collaborators of Yalong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yalong Wang. Yalong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yudong, Lizhe Zhu, Jiaqi Zhang, et al.. (2025). Axillary lymph node dissection offers no survival benefit in breast cancer patients with sentinel lymph node micrometastases after neoadjuvant therapy. Clinical and Experimental Medicine. 25(1). 319–319.

Zhou, Yudong, Shibo Yu, Lizhe Zhu, et al.. (2025). Molecular biomarkers for the prognosis of breast cancer: role of amino acid metabolism genes. Journal of Physiology and Biochemistry. 81(2). 441–457.

Du, Juan, Lizhe Zhu, Chaorui Duan, et al.. (2025). Clinical-genomic characteristics of homologous recombination deficiency (HRD) in breast cancer: application model for practice. European journal of medical research. 30(1). 249–249. 1 indexed citations

Wang, Yalong, Wei He, Leilei Shi, et al.. (2024). SART3 reads methylarginine-marked glycine- and arginine-rich motifs. Cell Reports. 43(7). 114459–114459. 3 indexed citations

Xu, Zhongyong, Yuting Luo, Zhiqing Xun, et al.. (2024). Rational design of a ratiometric indicator-displacement assay for the monitoring of chlortetracycline and intracellular imaging. Talanta. 284. 127251–127251. 3 indexed citations

Zhang, Zhongfang, Yalong Wang, Wei Wang, et al.. (2024). An Antiferromagnetic Neuromorphic Memory Based on Perpendicularly Magnetized CoO. Nano Letters. 24(36). 11187–11193. 4 indexed citations

Wang, Yalong, Sabrina A. Stratton, Manu Sebastian, et al.. (2023). Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma. Biochemical Journal. 480(22). 1805–1816. 1 indexed citations

Wan, Tingting, Yalong Wang, Kaixin He, & Shu Zhu. (2023). Microbial sensing in the intestine. Protein & Cell. 14(11). 824–860. 24 indexed citations

Yin, Shasha, Liu Liu, Lauren E. Ball, et al.. (2023). CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth. Cell Reports. 42(4). 112316–112316. 21 indexed citations

10.

Wang, Yalong & Mark T. Bedford. (2023). Effectors and effects of arginine methylation. Biochemical Society Transactions. 51(2). 725–734. 13 indexed citations

11.

He, Wei, Jinzhuang Dou, Oscar D. Villarreal, et al.. (2022). Systematic decomposition of sequence determinants governing CRISPR/Cas9 specificity. Nature Communications. 13(1). 474–474. 33 indexed citations

12.

Milite, Ciro, Vincent Cura, L. Bonnefond, et al.. (2022). Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction–Reconstruction and Fragment-Growing Approach. Journal of Medicinal Chemistry. 65(17). 11574–11606. 18 indexed citations

13.

Wang, Yalong, et al.. (2021). The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma. Epigenomes. 5(1). 2–2. 9 indexed citations

14.

Zhao, Xiaofang, Yuan Guan, Yalong Wang, et al.. (2021). SNARE Proteins Mediate α-Synuclein Secretion via Multiple Vesicular Pathways. Molecular Neurobiology. 59(1). 405–419. 12 indexed citations

15.

Wang, Yalong, Maria D. Person, & Mark T. Bedford. (2021). Pan-methylarginine antibody generation using PEG linked GAR motifs as antigens. Methods. 200. 80–86. 8 indexed citations

16.

Guan, Yuan, Xiaofang Zhao, Yalong Wang, et al.. (2020). Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein. Frontiers in Cellular Neuroscience. 14. 159–159. 35 indexed citations

17.

Lyu, Zhangyan, Fengwei Tan, Chunqing Lin, et al.. (2020). [The development and validation of risk prediction model for lung cancer: a systematic review].. PubMed. 54(4). 430–437. 3 indexed citations

18.

Cao, Yanhua, Yajuan Liu, Yalong Wang, et al.. (2019). Genome-wide identification of ZmHMAs and association of natural variation in ZmHMA2 and ZmHMA3 with leaf cadmium accumulation in maize. PeerJ. 7. e7877–e7877. 23 indexed citations

19.

Mao, Shuangshuang, Yuan Li, Zhiliang Lu, et al.. (2019). PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing. Cancer Medicine. 8(5). 2429–2441. 25 indexed citations

20.

Yao, Yikun, Yalong Wang, Fuxiang Chen, et al.. (2012). NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens. Cell Research. 22(5). 836–847. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact